OTSUKA HOLDINGS CO ADR

The pulmonary fibrosis market is driven by the increasing prevalence of the disease, especially idiopathic pulmonary fibrosis, among the aging population. Innovations in drug development and diagnostics, favorable reimbursement policies, and greater awareness are fueling market growth. The pipeline appears robust with over 110 active players working on 120+ pipeline drugs.

Related tickers: SNDX, PRTC, OTSKY, TRVI, SRPT, CTNM.

The global bipolar disorder market is expected to grow from $5.2 billion in 2023 to $7 billion by 2033, driven by increasing prevalence, government initiatives, and technological advancements. However, side effects of medications and misdiagnosis pose challenges.

Related tickers: ABBV, AZN, LLY, GSK, JNJ, NVS, PFE, OTSKY.